Navigation Links
Pharmos Corporation Reports First Quarter 2012 Results
Date:4/16/2012

ISELIN, N.J., April 16, 2012 /PRNewswire/ -- Pharmos Corporation (OTC-PINK: PARS) today reported financial results for the first quarter ended March 31, 2012. The Company recorded a net loss of $0.6 million, or $(0.01) per share, for the first quarter 2012 compared to a net loss of $0.6 million, or $(0.01) per share, in the first quarter 2011. 

The Company is currently conducting a clinical trial at the Duke Clinical Research Unit to evaluate levotofisopam as a treatment for gout. As of April 16, 2012, 13 patients have completed treatment. Serum urate concentration decreased in all patients, with a mean reduction of more than 45%. In addition, fractional excretion of urate increased, confirming the compound's mechanism of action as enhancing urate excretion. 

The Phase 2a trial is expected to be completed in May 2012 and the Company's strategy is to seek a partner for the further development of levotofisopam.

Research & development expenses for the first quarter increased by $8,880, or 3%, from $281,783 in 2011 to $290,663 in 2012. The primary areas include a $149,000 increase in clinical study fees which were offset by a $138,000 reduction in consultant and professional fees and a $2,000 reduction in various other areas. Clinical study fees increased as the clinical trial using levotofisopam to treat gout commenced in January 2012 and fees were incurred on completed patients. Consulting and professional fees have decreased as the Company filed the IND for the gout trial in 2011 while in 2012 there were normal expenses in this area.

General and administrative expenses for the first quarter of 2012 decreased by $34,288, or 12%, from $294,345 in 2011 to $260,057 in 2012. The primary reductions were a $15,000 reduction in consultant and professional fees, a $6,000 reduction in salaries and benefits and a $13,000 reduction in various other areas. Professional fees have decreased as there were reduced legal fees incur
'/>"/>

SOURCE Pharmos Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Pharmos Announces Clinical Results from Phase 2a Trial of Topical Diclofenac NanoEmulsion Cream
2. Pharmos Issues Business Update on Dextofisopam Trial and Financing
3. Pharmos Corporation Reports 2009 Third Quarter Results
4. Pharmos Corporation Reports Fourth Quarter and Full Year 2009 Results
5. Pharmos Corporation Reports 2010 Third Quarter Results
6. Pharmos Corporation Reports 2011 Second Quarter Results
7. Pharmos Corporation Reports 2011 Fourth Quarter and Full Year Results
8. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
9. CEL-SCI Corporation Releases Letter to Shareholders
10. Alfacell Corporation to Present at UBS Global Life Sciences Conference
11. Baxa Corporation Extends Global Reach With New Distribution Agreements in Colombia and the Dominican Republic
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... , Aug. 27, 2014 Kewaunee Scientific Corporation ... of Directors increased its quarterly cash dividend by 9% ... per outstanding share, beginning with the dividend payable on ... close of business on September 8, 2014. ... in 1906, Kewaunee Scientific Corporation is a recognized global ...
(Date:8/27/2014)... -- Columbia Laboratories, Inc. (Nasdaq: CBRX ) ("Columbia" ... trial manufacturing, and advanced analytical and consulting services to ... at the upcoming Rodman & Renshaw 16 th ... New York . The Company will present ... at the New York Palace Hotel. ...
(Date:8/27/2014)... and NINGBO, China , Aug. ... Ningbo Menovo Pharmaceutical Co., Ltd, ("Menovo") today announced they ... of generic pharmaceuticals, primarily targeting the United ... agreement, Amerigen and Menovo will jointly develop products for ... . Menovo will be responsible for manufacturing API ...
Breaking Medicine Technology:Amerigen Pharmaceuticals Limited and the Ningbo Menovo Pharmaceutical Co., Ltd, today announced they had entered into a collaboration agreement regarding the development of generic pharmaceuticals, primarily targeting the United States market 2
... N.J., Feb. 15, 2011 Daiichi Sankyo, Inc. (DSI), ... facility in Bethlehem Township, Pennsylvania from Amcor, a global ... leverage existing resources to more cost-effectively supplement its operations ... expected to be operational in the summer or early ...
... MAHWAH, N.J., Feb. 15, 2011 Stryker Corporation,s Orthopaedics ... most recognizable names and personalities in professional golf, has ... of the sport and current member of the PGA ... Triathlon ® Knee System in November 2009 and ...
Cached Medicine Technology:Daiichi Sankyo, Inc. Acquires First US-Based Packaging and Manufacturing Facility 2Fred Funk Becomes Spokesperson for Stryker Orthopaedics 2Fred Funk Becomes Spokesperson for Stryker Orthopaedics 3
(Date:8/28/2014)... York (PRWEB) August 28, 2014 An unprecedented ... and neck issues, Cloud 9 Spine offers their resources online ... problems can quickly become a brick wall of discouragement as ... a professional opinion, Cloud 9 Spine offers a ... technology merged with human interaction that sets Cloud 9 Spine ...
(Date:8/28/2014)... 28, 2014 Top 10 Best ... hosting companies and announces Bluehost, HostMonster ( http://www.hostmonster.com/track/seohosts ... for the webmasters worldwide who want to buy ... As the world’s most popular server-side scripting language, ... other general-purpose programs. It is now installed on ...
(Date:8/28/2014)... Now in its 4th year, Step ... 2011 by two brain aneurysm survivors. The ongoing mission of ... education to help increase early detection and to help support ... aneurysm. We hope that you will be able to join ... 4th Annual Step for Hope Run/ Walk on Saturday, September ...
(Date:8/28/2014)... CA (PRWEB) August 28, 2014 MarijuanaDoctors.com ... California physician, James Patel M.D. of Livermore, California. As ... best and most qualified physicians, and in accordance with ... our patients to Dr. Patel’s practice. , Initially finding ... a young age, Dr. Patel was shaped by his ...
(Date:8/28/2014)... 28, 2014 The Pulmonica is a ... resonant, meditative sounds that can be felt vibrating in ... to use it – just taking long, slow, deep ... , Here are some examples of how to ... your eyes, relax, and maintain good posture. Try to ...
Breaking Medicine News(10 mins):Health News:Making Waves on the East Coast, Cloud 9 Spine is Helping Patients Find Appointments With Local Spine Doctors 2Health News:Step for Hope and Raise Brain Aneurysm Awareness 2Health News:Army Colonel Dr. James Patel Joins the Medical Marijuana Industry 2Health News:Army Colonel Dr. James Patel Joins the Medical Marijuana Industry 3Health News:Army Colonel Dr. James Patel Joins the Medical Marijuana Industry 4Health News:Ever Thought of Meditating With a Harmonica; Harmonica Techs, Inventors of the Pulmonica® Pulmonary Harmonica®, Present Tips on How to Relax with Soothing Sounds 2
... favor of drugs in the pipeline, review finds , ... of drug studies published in major medical journals answer ... available medications works best for a particular condition. , ... effectiveness" studies, where experts seek to determine which available ...
... more than 80,000 who gave one up shows procedure carries ... a kidney carries few health risks, with donors living just ... donate, the largest study to date of donors has found. ... who donated a kidney between 1994 and 2009, researchers found ...
... ... ... ... ...
... , ... ... ... ...
... ... ... ... ...
... a certain type of genetic susceptibility to lung cancer ... with even a small exposure to cigarette smoke, a ... Cincinnati (UC) has concluded. For family members who carry ... similar for both light and heavy smokers, the researchers ...
Cached Medicine News:Health News:Most Drug Studies Don't Help Docs Pick Best Treatment 2Health News:Most Drug Studies Don't Help Docs Pick Best Treatment 3Health News:Kidney Donors Go On to Lead Long, Healthy Lives 2Health News:Kidney Donors Go On to Lead Long, Healthy Lives 3Health News:Introducing KePRO(TM) Engage Health - A Revolutionary Wellness & Lifestyle Management Company 2Health News:Introducing KePRO(TM) Engage Health - A Revolutionary Wellness & Lifestyle Management Company 3Health News:Introducing KePRO(TM) Engage Health - A Revolutionary Wellness & Lifestyle Management Company 4Health News:Introducing KePRO(TM) Engage Health - A Revolutionary Wellness & Lifestyle Management Company 5Health News:Online Tool Created to Contact Vatican Officials: 'Why Are American Bishops Allowed to Defy the Pope's Words Concerning Child Killing and the Eucharist?' 2Health News:Online Tool Created to Contact Vatican Officials: 'Why Are American Bishops Allowed to Defy the Pope's Words Concerning Child Killing and the Eucharist?' 3Health News:Online Tool Created to Contact Vatican Officials: 'Why Are American Bishops Allowed to Defy the Pope's Words Concerning Child Killing and the Eucharist?' 4Health News:Online Tool Created to Contact Vatican Officials: 'Why Are American Bishops Allowed to Defy the Pope's Words Concerning Child Killing and the Eucharist?' 5Health News:GoodTherapy.org and PsychCentral.com Partner to Help Therapy Seekers Find a Therapist 2Health News:GoodTherapy.org and PsychCentral.com Partner to Help Therapy Seekers Find a Therapist 3Health News:GoodTherapy.org and PsychCentral.com Partner to Help Therapy Seekers Find a Therapist 4Health News:GoodTherapy.org and PsychCentral.com Partner to Help Therapy Seekers Find a Therapist 5Health News:GoodTherapy.org and PsychCentral.com Partner to Help Therapy Seekers Find a Therapist 6Health News:Genetic variant greatly increases lung cancer risk for light smokers 2
... The SourceLink™ Delivery System offers a ... It addresses the challenges associated with ... provides the flexibility of seed and ... packaged per customers desired quantity and ...
... The Bard EXPRESS Seeding Cartridge System is ... delivering radioactive seeds and spacers into a ... Each cartridge has a(n): outer radiation safety ... synthetic absorbable spacers, integrally molded fitting that ...
... The Sysmex UF-100 is designed to ... microscopic analysis. It combines the superior ... automated urine sample analysis. Continuous sampling ... the rack-based autosamplers, streamlining sample processing in ...
... Q-Track II Holter Monitoring System uses technology ... the worlds first true 12-lead digital Holter ... of any beat contained in the 24-hour ... ,The preprocessing work done by the Q-12 ...
Medicine Products: